IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANTHONY VINCENT SANTALUCIA

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1023596947
CMS profile
10597091
Location
RICHMOND, VA

General Payments · PY2021–2024

$3,433.84

  • Reported across 166 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,091.82

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health VA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,091.82 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $385.22 15
Neurocrine BioSciences, Inc. $150.99 6
ITI, Inc. $150.58 10
ABBVIE INC. $90.71 6
Lundbeck LLC $90.53 4
Axsome Therapeutics, Inc. $86.78 5
Otsuka America Pharmaceutical, Inc. $75.88 3
E.R. Squibb & Sons, L.L.C. $39.60 2
Corium, Inc. $21.53 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $189.92 11
PY2022 $1,003.38 47
PY2023 $1,148.72 56
PY2024 $1,091.82 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $19.58 01/17/2024 Food and Beverage Undisputed 01/23/2026 1108143228 CMS
ABBVIE INC. $14.21 04/10/2024 Food and Beverage Undisputed 01/23/2026 1108143230 CMS
ABBVIE INC. $15.44 05/15/2024 Food and Beverage Undisputed 01/23/2026 1108143232 CMS
ABBVIE INC. $13.07 06/17/2024 Food and Beverage Undisputed 01/23/2026 1108143234 CMS
ABBVIE INC. $13.68 09/25/2024 Food and Beverage Undisputed 01/23/2026 1108143236 CMS
ABBVIE INC. $14.73 11/18/2024 Food and Beverage Undisputed 01/23/2026 1108143238 CMS
Axsome Therapeutics, Inc. $17.90 03/13/2024 Food and Beverage Undisputed 01/23/2026 1148337737 CMS
Axsome Therapeutics, Inc. $21.31 04/29/2024 Food and Beverage Undisputed 01/23/2026 1148337739 CMS
Axsome Therapeutics, Inc. $14.70 05/20/2024 Food and Beverage Undisputed 01/23/2026 1148337741 CMS
Axsome Therapeutics, Inc. $15.86 06/17/2024 Food and Beverage Undisputed 01/23/2026 1148337743 CMS
Axsome Therapeutics, Inc. $17.01 07/08/2024 Food and Beverage Undisputed 01/23/2026 1148337745 CMS
Corium, LLC $21.53 03/26/2024 Food and Beverage Undisputed 01/23/2026 1100092803 CMS
E.R. Squibb & Sons, L.L.C. $21.73 10/28/2024 Food and Beverage Undisputed 01/23/2026 1101355758 CMS
E.R. Squibb & Sons, L.L.C. $17.87 12/16/2024 Food and Beverage Undisputed 01/23/2026 1101355780 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.17 02/05/2024 Food and Beverage Undisputed 01/23/2026 1143598184 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.92 03/26/2024 Food and Beverage Undisputed 01/23/2026 1143598186 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.57 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143598188 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 1143598190 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.34 06/26/2024 Food and Beverage Undisputed 01/23/2026 1143598192 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.27 08/27/2024 Food and Beverage Undisputed 01/23/2026 1143598194 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.92 10/08/2024 Food and Beverage Undisputed 01/23/2026 1143598196 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.92 10/23/2024 Food and Beverage Undisputed 01/23/2026 1143598198 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.64 12/03/2024 Food and Beverage Undisputed 01/23/2026 1143598200 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.11 12/18/2024 Food and Beverage Undisputed 01/23/2026 1143598202 CMS
Lundbeck LLC $18.46 03/18/2024 Food and Beverage Undisputed 01/23/2026 1146086064 CMS
Lundbeck LLC $25.01 07/17/2024 Food and Beverage Undisputed 01/23/2026 1146086066 CMS
Lundbeck LLC $25.82 09/18/2024 Food and Beverage Undisputed 01/23/2026 1146086068 CMS
Lundbeck LLC $21.24 12/02/2024 Food and Beverage Undisputed 01/23/2026 1146086070 CMS
Neurocrine Biosciences, Inc. $17.96 02/15/2024 Food and Beverage Undisputed 01/23/2026 1150990290 CMS
Neurocrine Biosciences, Inc. $24.93 04/01/2024 Food and Beverage Undisputed 01/23/2026 1150955467 CMS
Neurocrine Biosciences, Inc. $31.19 05/23/2024 Food and Beverage Undisputed 01/23/2026 1150937278 CMS
Neurocrine Biosciences, Inc. $20.51 07/24/2024 Food and Beverage Undisputed 01/23/2026 1150977120 CMS
Neurocrine Biosciences, Inc. $30.71 09/09/2024 Food and Beverage Undisputed 01/23/2026 1150938152 CMS
Neurocrine Biosciences, Inc. $25.69 11/06/2024 Food and Beverage Undisputed 01/23/2026 1150952656 CMS
Otsuka America Pharmaceutical, Inc. $28.97 05/02/2024 Food and Beverage Undisputed 01/23/2026 1119179116 CMS
Otsuka America Pharmaceutical, Inc. $25.15 10/20/2024 Food and Beverage Undisputed 01/23/2026 1119179118 CMS
Otsuka America Pharmaceutical, Inc. $21.76 11/11/2024 Food and Beverage Undisputed 01/23/2026 1119179120 CMS
Teva Pharmaceuticals USA, Inc. $14.68 01/23/2024 Food and Beverage Undisputed 01/23/2026 1151735637 CMS
Teva Pharmaceuticals USA, Inc. $2.85 02/13/2024 Food and Beverage Undisputed 01/23/2026 1151735645 CMS
Teva Pharmaceuticals USA, Inc. $7.69 02/14/2024 Food and Beverage Undisputed 01/23/2026 1151735647 CMS
Teva Pharmaceuticals USA, Inc. $17.53 02/22/2024 Food and Beverage Undisputed 01/23/2026 1151735649 CMS
Teva Pharmaceuticals USA, Inc. $124.74 02/22/2024 Food and Beverage Undisputed 01/23/2026 1151735683 CMS
Teva Pharmaceuticals USA, Inc. $6.87 03/18/2024 Food and Beverage Undisputed 01/23/2026 1151735667 CMS
Teva Pharmaceuticals USA, Inc. $9.52 04/10/2024 Food and Beverage Undisputed 01/23/2026 1151735685 CMS
Teva Pharmaceuticals USA, Inc. $126.46 04/25/2024 Food and Beverage Undisputed 01/23/2026 1151735713 CMS
Teva Pharmaceuticals USA, Inc. $14.81 05/13/2024 Food and Beverage Undisputed 01/23/2026 1151735699 CMS
Teva Pharmaceuticals USA, Inc. $14.81 06/20/2024 Food and Beverage Undisputed 01/23/2026 1151735715 CMS
Teva Pharmaceuticals USA, Inc. $12.88 08/05/2024 Food and Beverage Undisputed 01/23/2026 1151735737 CMS
Teva Pharmaceuticals USA, Inc. $12.67 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151735751 CMS
Teva Pharmaceuticals USA, Inc. $2.78 10/07/2024 Food and Beverage Undisputed 01/23/2026 1151735757 CMS
Teva Pharmaceuticals USA, Inc. $7.09 10/16/2024 Food and Beverage Undisputed 01/23/2026 1151735759 CMS
Teva Pharmaceuticals USA, Inc. $9.84 10/30/2024 Food and Beverage Undisputed 01/23/2026 1151735761 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.